|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization expense | |||||
| Depreciation, amortization, and accretion | |||||
| Non-cash debt and financing costs | |||||
| Loss on debt extinguishment | |||||
| Non-cash interest income | |||||
| Stock-based compensation | |||||
| Asset impairment | |||||
| Gain on change in fair value of warrant liability | |||||
| Loss on impairment and sale of long-lived assets | |||||
| Provision for credit losses | |||||
| Gain on contribution to equity method investment | |||||
| Impairment of equity securities | |||||
| Change in fair value of derivative asset | |||||
| Change in fair value of financial instruments carried at fair value | |||||
| Non-cash expenses related to equity purchase agreement | |||||
| Deferred income taxes | |||||
| Foreign exchange losses | |||||
| Change in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Customer financing receivable | |||||
| Contract assets | |||||
| Prepaid expenses and other current assets | |||||
| Advances to suppliers | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Contract liabilities | |||||
| Other long-term liabilities | |||||
| Net cash used in operating activities | |||||
| Cash Flows From Investing Activities | |||||
| Purchase of property and equipment | |||||
| Investment in note receivable | |||||
| Purchase of property and equipment held for sale | |||||
| Purchase of equity securities | |||||
| Purchase of intangible assets | |||||
| Proceeds from sale of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities | |||||
| Proceeds from issuance of debt | |||||
| Repayment of debt | |||||
| Payment of debt issuance costs | |||||
| Proceeds from insurance premium financings | |||||
| Repayment of insurance premium financings | |||||
| Proceeds from issuance of redeemable non-controlling interest | |||||
| Payment of transaction costs related to redeemable non-controlling interest | |||||
| Proceeds from exercise of warrants | |||||
| Payment of transaction costs related to reverse recapitalization | |||||
| Short-swing profit recovery | |||||
| Proceeds from exercise of stock options | |||||
| Payment of finance lease obligations | |||||
| Payment of taxes related to net settlement of equity awards | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash – beginning of the period | |||||
| Cash, cash equivalents, and restricted cash – end of the period | |||||
| Less: restricted cash at end of period | |||||
| Cash and cash equivalents - end of period | |||||
| Supplemental Disclosures of Cash Flow Information: | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Supplemental Disclosures of Non-Cash Investing and Financing Information: | |||||
| Conversion of redeemable preferred stock into common stock in connection with the reverse recapitalization | |||||
| Warrants assumed as part of reverse recapitalization | |||||
| Actuarial gain (loss) on pension | |||||
| Property and equipment financed through accounts payable and accrued expenses and acquired though deferred payment obligation | |||||
| Assets acquired on finance lease | |||||
| Initial value of warrant liabilities | |||||
Loading...